Boule Diagnostics AB (publ) (BOUL.ST)
SEK 8.84
(-1.56%)
SEK 8.84
(-1.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 51.4 Million | -11.35 Million | 43.28 Million | 75.23 Million | 53.97 Million | 22.66 Million |
| Net Income | 25 Million | 28.97 Million | 36.01 Million | -5.92 Million | 70.02 Million | 54.83 Million |
| Depreciation & Amortization | 29.3 Million | 27.17 Million | 21.47 Million | 21.55 Million | 21.39 Million | 8.43 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.6 Million | -40.11 Million | -3.37 Million | 36.74 Million | -23.89 Million | -30.62 Million |
| Other non-cash items | -5.5 Million | -27.38 Million | -10.83 Million | 22.87 Million | -13.54 Million | -9.98 Million |
| Investing Cash Flow | -82.7 Million | -74.96 Million | -56.37 Million | -46 Million | -74.53 Million | -92.13 Million |
| Investments in PPE | -82.7 Million | -74.96 Million | -56.37 Million | -46 Million | -48.02 Million | -64.2 Million |
| Acquisitions | - | - | - | - | -26.51 Million | -27.92 Million |
| Investment purchases | - | - | - | - | -26.51 Million | -27.92 Million |
| Sales/Maturities of investments | - | - | - | - | 94.94 Million | - |
| Other Investing Activities | -1000.00 | -68.52 Million | -53.22 Million | 1000.00 | -68.43 Million | -80.66 Million |
| Financing Cash Flow | -25.5 Million | 140.55 Million | 15.75 Million | -14.88 Million | 11.61 Million | -435 Thousand |
| Debt repayment | -11.5 Million | -25.7 Million | -38.2 Million | -3.74 Million | -32.79 Million | -9.27 Million |
| Dividends payments | - | -10.67 Million | -10.67 Million | - | -10.67 Million | -9.7 Million |
| Common Stock Repurchased | - | -25.7 Million | - | - | - | - |
| Common Stock Issuance | -600 Thousand | 149.5 Million | - | - | - | - |
| Other Financing Activities | 491 Thousand | 53.13 Million | 64.63 Million | -11.13 Million | 55.08 Million | 9.27 Million |
| Accounts receivables | -19.2 Million | -15.14 Million | -33.7 Million | 41.84 Million | -25.9 Million | -22.94 Million |
| Accounts payables | 13 Million | -15.18 Million | 33.37 Million | -3.69 Million | 766 Thousand | -2 Million |
| Inventory | 8.8 Million | -9.77 Million | -3.04 Million | -1.4 Million | 1.25 Million | -5.67 Million |
| Other working capital | 13.03 Million | -15.18 Million | 33.37 Million | -3.69 Million | 766 Thousand | -24.94 Million |
| Cash at beginning of period | 96.9 Million | 38.18 Million | 32.98 Million | 21.58 Million | 30.25 Million | 99.16 Million |
| Cash at end of period | 37.3 Million | 96.9 Million | 38.18 Million | 32.98 Million | 21.58 Million | 30.25 Million |
| Capital Expenditure | -82.7 Million | -74.96 Million | -56.37 Million | -46 Million | -48.02 Million | -64.2 Million |
| Effect of forex changes on cash | -2.78 Million | 4.48 Million | 2.52 Million | -2.94 Million | 271 Thousand | 997 Thousand |
| Net cash flow / Change in cash | -59.6 Million | 58.72 Million | 5.19 Million | 11.4 Million | -8.67 Million | -68.9 Million |
| Free Cash Flow | -31.3 Million | -86.31 Million | -13.08 Million | 29.23 Million | 5.94 Million | -41.54 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -278.9 Million | -1.6 Million | 9.8 Million | 8.4 Million | 25 Million | 7.9 Million |
| Depreciation & Amortization | 6.2 Million | 4.5 Million | 7.1 Million | 10 Million | 29.3 Million | 6.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.8 Million | 18.4 Million | -13 Million | 14.6 Million | 2.6 Million | 18.9 Million |
| Other non-cash items | 289.9 Million | -16.9 Million | 35.8 Million | -3.9 Million | -5.5 Million | -5.2 Million |
| Investing Cash Flow | -16.5 Million | -25.2 Million | -21.4 Million | -21.4 Million | -82.7 Million | -22.7 Million |
| Investments in PPE | -16.5 Million | -25.3 Million | -21.4 Million | -21.3 Million | -82.7 Million | -22.7 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -13.2 Million | -23.5 Million | -19.5 Million | -100 Thousand | -1000.00 | -21.3 Million |
| Financing Cash Flow | -4.8 Million | 4.9 Million | 11.2 Million | -22 Million | -25.5 Million | 3.4 Million |
| Debt repayment | -6 Million | -8.3 Million | -14.8 Million | -18.4 Million | -11.5 Million | -6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 40 Thousand | -600 Thousand | 500 Thousand |
| Other Financing Activities | 1.2 Million | 8.3 Million | 14.6 Million | -12.4 Million | 491 Thousand | 8.9 Million |
| Accounts receivables | 10 Million | 10.1 Million | -11 Million | 1.2 Million | -19.2 Million | 11.8 Million |
| Accounts payables | -16.39 Million | 9.7 Million | 1.9 Million | 2.9 Million | 13 Million | -300 Thousand |
| Inventory | 600 Thousand | -1.4 Million | -3.9 Million | 10.5 Million | 8.8 Million | 7.5 Million |
| Other working capital | -16.4 Million | 9.6 Million | 1.9 Million | 2.93 Million | 13.03 Million | -100 Thousand |
| Cash at beginning of period | 34.7 Million | 40.9 Million | 37.28 Million | 52.9 Million | 96.9 Million | 45.9 Million |
| Cash at end of period | 17.2 Million | 34.7 Million | 40.9 Million | 37.3 Million | 37.3 Million | 52.9 Million |
| Capital Expenditure | -16.5 Million | -25.3 Million | -21.4 Million | -21.3 Million | -82.7 Million | -22.7 Million |
| Effect of forex changes on cash | -1.4 Million | 500 Thousand | 1.2 Million | -1.28 Million | -2.78 Million | -1.6 Million |
| Net cash flow / Change in cash | -17.5 Million | -6.2 Million | 3.61 Million | -15.6 Million | -59.6 Million | 7 Million |
| Free Cash Flow | -11.3 Million | -11.5 Million | -8.9 Million | 7.8 Million | -31.3 Million | 5.1 Million |
MSAIW
BKOR
SINCH
USMJ
CCPA
5616